{
    "2018-11-01": [
        [
            {
                "time": "2018-11-05",
                "original_text": "Gene therapy: CHOP unveils $75M manufacturing facility (Photos)",
                "features": {
                    "keywords": [
                        "gene therapy",
                        "CHOP",
                        "manufacturing facility"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-06",
                "original_text": "Call buyers take position in Novartis",
                "features": {
                    "keywords": [
                        "call buyers",
                        "Novartis",
                        "take position"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "Glaxo (GSK) Beats on Q3 Earnings & Sales, Raises '18 View",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Q3 Earnings",
                        "Raises '18 View"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-08",
                "original_text": "FDA Approves 3rd Humira Biosimilar, CLVS Tanks On Q3 Results, CRY On Watch",
                "features": {
                    "keywords": [
                        "FDA",
                        "Humira Biosimilar",
                        "CLVS Tanks",
                        "Q3 Results"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}